These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 18338133)

  • 1. Role of perfusion-weighted imaging at 3 Tesla in the assessment of malignancy of cerebral gliomas.
    Di Costanzo A; Pollice S; Trojsi F; Giannatempo GM; Popolizio T; Canalis L; Armillotta M; Maggialetti A; Carriero A; Tedeschi G; Scarabino T
    Radiol Med; 2008 Feb; 113(1):134-43. PubMed ID: 18338133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-grade and low-grade gliomas: differentiation by using perfusion MR imaging.
    Hakyemez B; Erdogan C; Ercan I; Ergin N; Uysal S; Atahan S
    Clin Radiol; 2005 Apr; 60(4):493-502. PubMed ID: 15767107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Solitary metastases and high-grade gliomas: radiological differentiation by morphometric analysis and perfusion-weighted MRI.
    Hakyemez B; Erdogan C; Gokalp G; Dusak A; Parlak M
    Clin Radiol; 2010 Jan; 65(1):15-20. PubMed ID: 20103416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glial neoplasms: dynamic contrast-enhanced T2*-weighted MR imaging.
    Knopp EA; Cha S; Johnson G; Mazumdar A; Golfinos JG; Zagzag D; Miller DC; Kelly PJ; Kricheff II
    Radiology; 1999 Jun; 211(3):791-8. PubMed ID: 10352608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glial tumor grading and outcome prediction using dynamic spin-echo MR susceptibility mapping compared with conventional contrast-enhanced MR: confounding effect of elevated rCBV of oligodendrogliomas [corrected].
    Lev MH; Ozsunar Y; Henson JW; Rasheed AA; Barest GD; Harsh GR; Fitzek MM; Chiocca EA; Rabinov JD; Csavoy AN; Rosen BR; Hochberg FH; Schaefer PW; Gonzalez RG
    AJNR Am J Neuroradiol; 2004 Feb; 25(2):214-21. PubMed ID: 14970020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical relevance of diffusion and perfusion magnetic resonance imaging in assessing intra-axial brain tumors.
    Rollin N; Guyotat J; Streichenberger N; Honnorat J; Tran Minh VA; Cotton F
    Neuroradiology; 2006 Mar; 48(3):150-9. PubMed ID: 16470375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Echo-planar MR determination of relative cerebral blood volume in human brain tumors: T1 versus T2 weighting.
    Bruening R; Kwong KK; Vevea MJ; Hochberg FH; Cher L; Harsh GR; Niemi PT; Weisskoff RM; Rosen BR
    AJNR Am J Neuroradiol; 1996 May; 17(5):831-40. PubMed ID: 8733954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brain abscess and cystic brain tumor: discrimination with dynamic susceptibility contrast perfusion-weighted MRI.
    Erdogan C; Hakyemez B; Yildirim N; Parlak M
    J Comput Assist Tomogr; 2005; 29(5):663-7. PubMed ID: 16163039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparing perfusion metrics obtained from a single compartment versus pharmacokinetic modeling methods using dynamic susceptibility contrast-enhanced perfusion MR imaging with glioma grade.
    Law M; Young R; Babb J; Rad M; Sasaki T; Zagzag D; Johnson G
    AJNR Am J Neuroradiol; 2006 Oct; 27(9):1975-82. PubMed ID: 17032878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Using relative cerebral blood flow and volume to evaluate the histopathologic grade of cerebral gliomas: preliminary results.
    Shin JH; Lee HK; Kwun BD; Kim JS; Kang W; Choi CG; Suh DC
    AJR Am J Roentgenol; 2002 Sep; 179(3):783-9. PubMed ID: 12185064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic performance of texture analysis on MRI in grading cerebral gliomas.
    Skogen K; Schulz A; Dormagen JB; Ganeshan B; Helseth E; Server A
    Eur J Radiol; 2016 Apr; 85(4):824-9. PubMed ID: 26971430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dynamic contrast-enhanced T2*-weighted MR imaging of gliomatosis cerebri.
    Yang S; Wetzel S; Law M; Zagzag D; Cha S
    AJNR Am J Neuroradiol; 2002 Mar; 23(3):350-5. PubMed ID: 11900998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiparametric 3T MR approach to the assessment of cerebral gliomas: tumor extent and malignancy.
    Di Costanzo A; Scarabino T; Trojsi F; Giannatempo GM; Popolizio T; Catapano D; Bonavita S; Maggialetti N; Tosetti M; Salvolini U; d'Angelo VA; Tedeschi G
    Neuroradiology; 2006 Sep; 48(9):622-31. PubMed ID: 16752135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assesment of perfusion in glial tumors with arterial spin labeling; comparison with dynamic susceptibility contrast method.
    Cebeci H; Aydin O; Ozturk-Isik E; Gumus C; Inecikli F; Bekar A; Kocaeli H; Hakyemez B
    Eur J Radiol; 2014 Oct; 83(10):1914-9. PubMed ID: 25087109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of a first-pass gradient-echo spin-echo method to predict brain tumor grade and angiogenesis.
    Schmainda KM; Rand SD; Joseph AM; Lund R; Ward BD; Pathak AP; Ulmer JL; Badruddoja MA; Krouwer HG
    AJNR Am J Neuroradiol; 2004 Oct; 25(9):1524-32. PubMed ID: 15502131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of different cerebral mass lesions by perfusion-weighted MR imaging.
    Hakyemez B; Erdogan C; Bolca N; Yildirim N; Gokalp G; Parlak M
    J Magn Reson Imaging; 2006 Oct; 24(4):817-24. PubMed ID: 16958061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerebral abscesses and necrotic cerebral tumours: differential diagnosis by perfusion-weighted magnetic resonance imaging.
    Muccio CF; Esposito G; Bartolini A; Cerase A
    Radiol Med; 2008 Aug; 113(5):747-57. PubMed ID: 18414811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conventional MR imaging with simultaneous measurements of cerebral blood volume and vascular permeability in ganglioglioma.
    Law M; Meltzer DE; Wetzel SG; Yang S; Knopp EA; Golfinos J; Johnson G
    Magn Reson Imaging; 2004 Jun; 22(5):599-606. PubMed ID: 15172052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation between dynamic susceptibility contrast perfusion MRI and methionine metabolism in brain gliomas: preliminary results.
    Sadeghi N; Salmon I; Tang BN; Denolin V; Levivier M; Wikler D; Rorive S; Balériaux D; Metens T; Goldman S
    J Magn Reson Imaging; 2006 Nov; 24(5):989-94. PubMed ID: 17031832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison between CT and MR in perfusion imaging assessment of high-grade gliomas.
    De Simone M; Muccio CF; Pagnotta SM; Esposito G; Cianfoni A
    Radiol Med; 2013 Feb; 118(1):140-51. PubMed ID: 22430675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.